Skip to main content
Erschienen in: Journal of Neuro-Oncology 1/2017

18.04.2017 | Topic Review

The role of tumor board conferences in neuro-oncology: a nationwide provider survey

verfasst von: James Snyder, Lonni Schultz, Tobias Walbert

Erschienen in: Journal of Neuro-Oncology | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

The tumor board or multidisciplinary cancer meeting (MCM) is the foundation of high value multidisciplinary oncology care, coordinating teams of specialists. Little is known on how these meetings are implemented in Neuro-oncology. Benefits of MCMs include coordination, direction for complicated cases, education, and a forum for communication, emerging technology, and clinical trials. This study identifies participation and utilization of neuro-oncology MCMs. A cross-sectional descriptive survey was dispersed through an internet questionnaire. The Society of Neuro-Oncology and the American Brain Tumor Association provided a list of dedicated neuro-oncology centers. All National Cancer Institute designated centers, and participants in the Adult Brain Tumor Consortium or the Brain Tumor Trials Collaborative were included, identifying 85 centers. Discussion included primary brain tumors (100%), challenging cases (98%), recurrent disease (96%), neoplastic spine disease (93%), metastatic brain lesions (89%), pre-surgical cases (82%), pathology (76%), and paraneoplastic disease (40%). MCMs were composed of neuro-oncologists, neurosurgeons, and radiation oncologists (100%), radiologists (98%), pathologists (96%), and clinical trial participants (64%). Individual preparation ranged from 15 to 300 min. MCMs were valued for clinical decision making (94%), education (89%), and access to clinical trials (69%). 13% documented MCMs in the medical record. 38% of centers used a molecular tumor board; however, many commented with uncertainty as to how this is defined. Neuro-oncology MCMs at leading U.S. institutions demonstrate congruity of core disciplines, cases discussed, and perceived value. We identified variability in preparation time and implementation of MCM recommendations. There is high uncertainty as to the definition and application of a molecular tumor board.
Literatur
1.
Zurück zum Zitat El Saghir NS, Charara RN, Kreidieh FY, Eaton V, Litvin K, Farhat RA, Khoury KE, Breidy J, Tamim H, Eid TA (2015) Global practice and efficiency of multidisciplinary tumor boards: results of an American Society of Clinical Oncology international survey. J Glob Oncol 1(2):57–64CrossRef El Saghir NS, Charara RN, Kreidieh FY, Eaton V, Litvin K, Farhat RA, Khoury KE, Breidy J, Tamim H, Eid TA (2015) Global practice and efficiency of multidisciplinary tumor boards: results of an American Society of Clinical Oncology international survey. J Glob Oncol 1(2):57–64CrossRef
4.
Zurück zum Zitat ASCO-ESMO (2006) ASCO-ESMO consensus statement on quality cancer care. Ann Oncol 17(7):1063–1064CrossRef ASCO-ESMO (2006) ASCO-ESMO consensus statement on quality cancer care. Ann Oncol 17(7):1063–1064CrossRef
5.
Zurück zum Zitat Merkow RP, Chung JW, Paruch JL, Bentrem DJ, Bilimori KY (2014) Relationship between cancer center accreditation and performance on publicly reported quality measures. Ann Surg 259(6):1091–1097CrossRefPubMed Merkow RP, Chung JW, Paruch JL, Bentrem DJ, Bilimori KY (2014) Relationship between cancer center accreditation and performance on publicly reported quality measures. Ann Surg 259(6):1091–1097CrossRefPubMed
7.
Zurück zum Zitat Charara RN, Kreidieh FY, Farhat RA, et al (2016) Practice and impact of multidisciplinary tumor boards on patient management: a prospective study. J Glob Oncol. doi:10.1200/JGO.2016.004960 (Abstract) Charara RN, Kreidieh FY, Farhat RA, et al (2016) Practice and impact of multidisciplinary tumor boards on patient management: a prospective study. J Glob Oncol. doi:10.​1200/​JGO.​2016.​004960 (Abstract)
8.
Zurück zum Zitat Lamb BW, Brown KF, Nagpal K, Vincent C, Green JS, Sevdalis N (2011) Quality of care management decisions by multidisciplinary cancer teams: a systematic review. Ann Surg Oncol 18(8):2116–2125CrossRefPubMed Lamb BW, Brown KF, Nagpal K, Vincent C, Green JS, Sevdalis N (2011) Quality of care management decisions by multidisciplinary cancer teams: a systematic review. Ann Surg Oncol 18(8):2116–2125CrossRefPubMed
9.
Zurück zum Zitat Scher KS, Tisnado DM, Rose DE, Adams JL, Ko CY, Malin JL, Ganz PA, Kahn KL (2011) Physician and practice characteristics influencing tumor board attendance: results from the provider survey of the Los Angeles Women’s Health Study. J Oncol Pract 7(2):103–110CrossRefPubMedPubMedCentral Scher KS, Tisnado DM, Rose DE, Adams JL, Ko CY, Malin JL, Ganz PA, Kahn KL (2011) Physician and practice characteristics influencing tumor board attendance: results from the provider survey of the Los Angeles Women’s Health Study. J Oncol Pract 7(2):103–110CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Lamb BW, Sevdalis N, Arora S, Pinto A, Vincent C, Green JS (2011) Teamwork and team decision-making at multidisciplinary cancer conferences: barriers, facilitators, and opportunities for improvement. World J Surg 35(9):1970–1976CrossRefPubMed Lamb BW, Sevdalis N, Arora S, Pinto A, Vincent C, Green JS (2011) Teamwork and team decision-making at multidisciplinary cancer conferences: barriers, facilitators, and opportunities for improvement. World J Surg 35(9):1970–1976CrossRefPubMed
11.
Zurück zum Zitat El Saghir NS, Keating NL, Carlson RW, Khoury KE, Fallowfield L (2014) Tumor boards: optimizing the structure and improving efficiency of multidisciplinary management of patients with cancer worldwide. Am Soc Clin Oncol Educ Book e461–466 El Saghir NS, Keating NL, Carlson RW, Khoury KE, Fallowfield L (2014) Tumor boards: optimizing the structure and improving efficiency of multidisciplinary management of patients with cancer worldwide. Am Soc Clin Oncol Educ Book e461–466
12.
Zurück zum Zitat Fennell ML, Das IP, Clauser S, Petrelli N, Salner A (2010) The organization of multidisciplinary care teams: modeling internal and external influences on cancer care quality. J Natl Cancer Inst Monogr 2010(40):72–80CrossRefPubMedPubMedCentral Fennell ML, Das IP, Clauser S, Petrelli N, Salner A (2010) The organization of multidisciplinary care teams: modeling internal and external influences on cancer care quality. J Natl Cancer Inst Monogr 2010(40):72–80CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Ruhstaller T, Roe H, Thürlimann B, Nicoll JJ (2006) The multidisciplinary meeting: an indispensable aid to communication between different specialities. Eur J Cancer 42(15):2459–2462CrossRefPubMed Ruhstaller T, Roe H, Thürlimann B, Nicoll JJ (2006) The multidisciplinary meeting: an indispensable aid to communication between different specialities. Eur J Cancer 42(15):2459–2462CrossRefPubMed
14.
Zurück zum Zitat American Society of Clinical Oncology (2014) The state of cancer care in America, 2014: a report by the American Society of Clinical Oncology. J Oncol Pract 10(2):119–142CrossRef American Society of Clinical Oncology (2014) The state of cancer care in America, 2014: a report by the American Society of Clinical Oncology. J Oncol Pract 10(2):119–142CrossRef
15.
Zurück zum Zitat Kuroki L, Stuckey A, Hirway P, Raker CA, Bandera CA, DiSilvestro PA, Grannai CO, Legare RD, Sakr BJ, Dizon DS (2010) Addressing clinical trials: can the multidisciplinary Tumor Board improve participation? A study from an academic women’s cancer program. Gynecol Oncol 116(3):295–300CrossRefPubMed Kuroki L, Stuckey A, Hirway P, Raker CA, Bandera CA, DiSilvestro PA, Grannai CO, Legare RD, Sakr BJ, Dizon DS (2010) Addressing clinical trials: can the multidisciplinary Tumor Board improve participation? A study from an academic women’s cancer program. Gynecol Oncol 116(3):295–300CrossRefPubMed
16.
Zurück zum Zitat Newman EA, Guest AB, Helvie MA, Roubidoux MA, Chang AE, Kleer OG, Diehl KM, Cimmino VM, Pierce L, Hayes D, Newman LA, Sabel MS (2006) Changes in surgical management resulting from case review at a breast cancer multidisciplinary tumor board. Cancer 107(10):2346–2351CrossRefPubMed Newman EA, Guest AB, Helvie MA, Roubidoux MA, Chang AE, Kleer OG, Diehl KM, Cimmino VM, Pierce L, Hayes D, Newman LA, Sabel MS (2006) Changes in surgical management resulting from case review at a breast cancer multidisciplinary tumor board. Cancer 107(10):2346–2351CrossRefPubMed
17.
Zurück zum Zitat Kesson EM, Allardice GM, George WD, Burns HJ, Morrison DS (2012) Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13,722 women. BMJ 344:e2718CrossRefPubMedPubMedCentral Kesson EM, Allardice GM, George WD, Burns HJ, Morrison DS (2012) Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13,722 women. BMJ 344:e2718CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Keating NL, Landrum MB, Lamont EB, Bozeman SR, Shulman LN, McNeil BJ (2013) Tumor boards and the quality of cancer care. J Natl Cancer Inst 105(23):113–121CrossRefPubMedPubMedCentral Keating NL, Landrum MB, Lamont EB, Bozeman SR, Shulman LN, McNeil BJ (2013) Tumor boards and the quality of cancer care. J Natl Cancer Inst 105(23):113–121CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Taplin SH, Weaver S, Salas E, Cholette V, Edwards HM, Bruinooge SS, Kosty MP (2015) Reviewing cancer care team effectiveness. J Oncol Pract Am Soc Clin Oncol 11(3):239–246CrossRef Taplin SH, Weaver S, Salas E, Cholette V, Edwards HM, Bruinooge SS, Kosty MP (2015) Reviewing cancer care team effectiveness. J Oncol Pract Am Soc Clin Oncol 11(3):239–246CrossRef
20.
Zurück zum Zitat Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG (2009) Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42(2):377–381CrossRefPubMed Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG (2009) Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42(2):377–381CrossRefPubMed
21.
Zurück zum Zitat Pentland A (2012) The new science of building great teams. Harv Bus Rev 90:60–69 Pentland A (2012) The new science of building great teams. Harv Bus Rev 90:60–69
22.
Zurück zum Zitat Okada H, Weller M, Huang R, Finocchiaro G, Gilbert MR, Wick W, Ellingson BM, Hashimoto N, Pollack IF, Brandes AA, Franceschi E, Herold-Mende C, Nayak L, Panigrahy A, Pope WB, Prins R, Sampson JH, Wen PY, Reardon DA (2015) Immunotherapy response assessment in neuro-oncology: a report of the RANO working group. Lancet Oncol 16(15):e534–e542CrossRefPubMedPubMedCentral Okada H, Weller M, Huang R, Finocchiaro G, Gilbert MR, Wick W, Ellingson BM, Hashimoto N, Pollack IF, Brandes AA, Franceschi E, Herold-Mende C, Nayak L, Panigrahy A, Pope WB, Prins R, Sampson JH, Wen PY, Reardon DA (2015) Immunotherapy response assessment in neuro-oncology: a report of the RANO working group. Lancet Oncol 16(15):e534–e542CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Sidhom MA, Poulsen MG (2006) Multidisciplinary care in oncology: medicolegal implications of group decisions. Lancet Oncol 7(11):951–954CrossRefPubMed Sidhom MA, Poulsen MG (2006) Multidisciplinary care in oncology: medicolegal implications of group decisions. Lancet Oncol 7(11):951–954CrossRefPubMed
24.
Zurück zum Zitat Blayney DW (2013) Tumor boards (Team Huddles) aren’t enough to reach the goal. J Natl Cancer Inst 105(2):82–84CrossRefPubMed Blayney DW (2013) Tumor boards (Team Huddles) aren’t enough to reach the goal. J Natl Cancer Inst 105(2):82–84CrossRefPubMed
25.
Zurück zum Zitat Taylor C, Ramirez A (2009) Multidisciplinary team member’s views about MDT working: results from a survey commisioned by the National Cancer Action Team. NHS National Cancer Action Team, London Taylor C, Ramirez A (2009) Multidisciplinary team member’s views about MDT working: results from a survey commisioned by the National Cancer Action Team. NHS National Cancer Action Team, London
26.
Zurück zum Zitat Katterhagen JG, Wishart DL (1977) The tumor board—How it works in a community hospital. CA Cancer J Clin 27(4):201–204CrossRefPubMed Katterhagen JG, Wishart DL (1977) The tumor board—How it works in a community hospital. CA Cancer J Clin 27(4):201–204CrossRefPubMed
27.
Zurück zum Zitat De Ieso PB, Coward JI, Letsa I, Schick U, Nandhabalan M, Fretzas S, Gore ME (2013) A study of the decision outcomes and financial costs of multidisciplinary team meetings (MDMs) in oncology. Br J Cancer 109(9):2295–2300CrossRefPubMedPubMedCentral De Ieso PB, Coward JI, Letsa I, Schick U, Nandhabalan M, Fretzas S, Gore ME (2013) A study of the decision outcomes and financial costs of multidisciplinary team meetings (MDMs) in oncology. Br J Cancer 109(9):2295–2300CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavanee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131(6):803–820CrossRefPubMed Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavanee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131(6):803–820CrossRefPubMed
29.
Zurück zum Zitat Fleissig A, Jenkins V, Catt S, Fallowfield L (2006) Multidisciplinary teams in cancer care: are they effective in the UK? Lancet Oncol 7(11):935–943CrossRefPubMed Fleissig A, Jenkins V, Catt S, Fallowfield L (2006) Multidisciplinary teams in cancer care: are they effective in the UK? Lancet Oncol 7(11):935–943CrossRefPubMed
Metadaten
Titel
The role of tumor board conferences in neuro-oncology: a nationwide provider survey
verfasst von
James Snyder
Lonni Schultz
Tobias Walbert
Publikationsdatum
18.04.2017
Verlag
Springer US
Erschienen in
Journal of Neuro-Oncology / Ausgabe 1/2017
Print ISSN: 0167-594X
Elektronische ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-017-2416-x

Weitere Artikel der Ausgabe 1/2017

Journal of Neuro-Oncology 1/2017 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Neu im Fachgebiet Neurologie

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.